Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657566 · ClinicalTrials.gov registry record · Phase 3
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
A Phase 3 study of Peritonitis, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 3
- Development phase
- 518
- Enrollment target
- 20
- Study locations
NCT00657566: Completed Phase 3 study of Peritonitis, sponsored by University of Virginia.
NCT00657566 is a Phase 3 study of Peritonitis that has completed, run by University of Virginia. The registered enrollment target is 518 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00657566, a Phase 3 study of Peritonitis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 518 participants
- Enrollment target
- 20
- Study locations
Study Summary
The major hypothesis to be tested is that the treatment of intraabdominal infections that have been adequately treated operatively or by percutaneous techniques with three to five days of antibiotics will result in outcomes equivalent to the current standard where treatment is carried out until the patient has returned to normal (normal white blood cell count, temperature, and intestinal function), and that patients treated for three to five days will receive fewer days of antibiotics than the control group that has traditionally received seven to 14 days of treatment.
Conditions Studied
Interventions
- OTHER duration of antibiotics
Study Locations (20)
California
- University of California Davis - Sacramento
- University of California San Diego - San Diego
- University of California San Francisco - San Francisco
Kentucky
- Louisville-VA - Louisville
- Louisville-University Hospital - Louisville
Ohio
- Case Western - Cleveland
- Ohio State University - Columbus
Virginia
- University of Virginia - Charlottesville
- Medical College of Virginia-Virginia Commonwealth University Hospital - Richmond
Arizona
- Maricopa Medical Center-Phoenix - Phoenix
Florida
- University of Miami - Miami
Kansas
- Univestity of Kansas - Kansas City
Maryland
- Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
What the finished NCT00657566 record still lists
NCT00657566 is an interventional study that assigns participants to a tested intervention. The registered 518 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Peritonitis appearing as the primary indexed condition, and to 1 intervention - of which duration of antibiotics is the first listed.
NCT00657566 names 20 study sites across 15 states, led by California, Kentucky, Ohio.
Frequently Asked Questions
What is clinical trial NCT00657566 about?
NCT00657566 is a clinical study titled "SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection". The major hypothesis to be tested is that the treatment of intraabdominal infections that have been adequately treated operatively or by percutaneous techniques with three to five days of antibiotics will result in outcomes equivalent to the current standard where treatment is carried out until the ...
What is the current status of trial NCT00657566?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 518 participants. The study started on 2008-09. Estimated completion is 2014-08.
What conditions does trial NCT00657566 study?
This clinical trial studies the following conditions: Peritonitis.
What interventions are being tested in trial NCT00657566?
The interventions under investigation include: duration of antibiotics (OTHER).
Who is sponsoring clinical trial NCT00657566?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00657566 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00657566's enrollment target sits among peer trials
518 723rd of 2000 higher than 1,277 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04524871 · 518 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- NCT07112196 · 518 participants · Phase 2
Visugromab in Cachexia International Trial
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia